Arcosa
ACA
146.40
-0.10
-0.07%
Arcosa
US · ACA
#1756 by market cap
Listed 1970
146.40
-0.10
-0.07%
Live - 5344 symbols - heartbeat 365s ago
· 2026-10-07 20:27
After-hours
146.40
0.00%
Overnight
146.62
+0.15%
- Market cap
- 7.19B
- P/E (TTM)i
- 14.68
- P/Bi
- 2.41
- EPSi
- 4.24
- Div yieldi
- 0.14%
- 52W posi
- 99%
Reader sentiment
Are you bullish or bearish on ACA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.06, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +12.20% YoY
Margins
- Gross margin
- 22.45%
- Operating margin
- 11.86%
- Net margin
- 7.21%
Key ratios & quality
- Enterprise valuei
- 8.50B
- Altman Z-Scorei
- 3.06
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.46B | 1.74B | 1.94B | 2.04B | 2.24B | 2.31B | 2.57B | 2.88B |
| Gross profit | 272.00M | 332.40M | 382.00M | 355.90M | 411.10M | 443.80M | 515.20M | 647.20M |
| Selling & admin expenses | 153.90M | 179.50M | 223.10M | 256.00M | 262.80M | 261.10M | 320.00M | 307.10M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 118.10M | 152.90M | 158.90M | 99.90M | 148.30M | 217.30M | 197.60M | 341.90M |
| Pretax profit | 95.00M | 146.80M | 138.20M | 83.60M | 316.20M | 195.90M | 130.00M | 241.30M |
| Tax | 19.30M | 33.50M | 31.60M | 14.00M | 70.40M | 36.70M | 36.30M | 32.90M |
| Net profit | 75.70M | 113.30M | 106.60M | 69.60M | 245.80M | 159.20M | 93.70M | 208.40M |
| Basic EPS | 2 | 2 | 2 | 1 | 5 | 3 | 2 | 4 |
| Diluted EPS | 1.54 | 2.32 | 2.18 | 1.42 | 5.05 | 3.26 | 1.91 | 4.24 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 547.60M | 647.50M | 797.80M | 716.70M | 571.70M | 658.70M |
| Gross profit | 107.90M | 150.30M | 191.90M | 163.80M | 120.90M | 155.70M |
| Selling & admin expenses | 71.00M | 70.00M | 82.20M | 78.20M | 75.80M | 89.10M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 41.00M | 82.00M | 112.30M | 79.00M | 47.10M | 84.30M |
| Pretax profit | 14.40M | 57.00M | 87.10M | 55.20M | 24.60M | 62.30M |
| Tax | 2.80M | 6.50M | 14.10M | 3.10M | 1.30M | 11.40M |
| Net profit | 23.60M | 59.70M | 73.00M | 52.10M | 37.80M | 328.50M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 7 |
| Diluted EPS | 0.48 | 1.22 | 1.48 | 1.06 | 0.77 | 6.67 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 667.40M | 757.20M | 664.90M | 767.90M | 856.80M | 912.00M | 954.00M | 1.11B |
| Cash & ST investments | 99.40M | 240.40M | 95.80M | 72.90M | 160.40M | 104.80M | 187.30M | 214.60M |
| Inventory | 252.50M | 283.30M | 276.80M | 324.50M | 315.80M | 401.80M | 359.90M | 424.20M |
| Total assets | 2.17B | 2.30B | 2.65B | 3.19B | 3.34B | 3.58B | 4.92B | 4.99B |
| Total current liabilities | 209.50M | 284.00M | 310.30M | 364.00M | 367.70M | 431.20M | 516.00M | 503.60M |
| Short-term debt | 1.80M | 3.70M | 6.30M | 14.80M | 14.70M | 6.80M | 12.10M | 8.50M |
| Long-term debt | 183.70M | 103.60M | 248.20M | 664.70M | 535.90M | 561.90M | 1.68B | 1.51B |
| Total liabilities | 487,700,000.00 | 512,100,000.00 | 754,500,000.00 | 1,234,800,000.00 | 1,156,200,000.00 | 1,245,900,000.00 | 2,487,300,000.00 | 2,343,800,000.00 |
| Total equity | 1.68B | 1.79B | 1.89B | 1.95B | 2.18B | 2.33B | 2.43B | 2.64B |
| Retained earnings | 19.50M | 122.90M | 219.70M | 279.50M | 515.50M | 664.90M | 748.90M | 947.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 1.12B | 1.17B | 1.11B | 1.13B | 1.41B |
| Cash & ST investments | 167.90M | 189.70M | 220.00M | 214.60M | 153.20M | 432.10M |
| Inventory | 365.00M | 406.80M | 420.70M | 424.20M | 350.00M | 364.20M |
| Total assets | 4.93B | 5.01B | 5.05B | 4.99B | 5.00B | 5.30B |
| Total current liabilities | 510.00M | 527.50M | 579.70M | 503.60M | 489.60M | 452.30M |
| Short-term debt | 11.20M | 10.20M | 9.30M | 8.50M | 8.00M | 7.70M |
| Long-term debt | 1.68B | 1.67B | 1.57B | 1.51B | 1.51B | 1.43B |
| Total liabilities | 2,479,400,000.00 | 2,503,300,000.00 | 2,468,100,000.00 | 2,343,800,000.00 | 2,349,600,000.00 | 2,318,600,000.00 |
| Total equity | 2.45B | 2.51B | 2.58B | 2.64B | 2.65B | 2.98B |
| Retained earnings | 770.00M | 827.20M | 897.70M | 947.30M | 982.70M | 1.31B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 118.50M | 358.80M | 259.90M | 166.50M | 174.30M | 261.00M | 502.00M | 341.10M |
| Depreciation & amortization | 67.60M | 85.80M | 114.50M | 144.30M | 154.10M | 159.50M | 195.00M | 223.00M |
| Free cash flow | 73.70M | 273.40M | 177.80M | 81.40M | 36.30M | 57.50M | 312.30M | 175.50M |
| Dividends paid | 0 | -9.90M | -9.80M | -9.80M | -9.80M | -9.80M | -9.70M | -10.00M |
| Stock buybacks / issuance | -3.50M | -15.40M | -11.80M | -19.50M | -27.50M | -25.20M | -10.60M | -12.90M |
| Ending cash balance | 99.40M | 240.40M | 95.80M | 72.90M | 160.40M | 104.80M | 187.30M | 214.60M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -700.00K | 61.20M | 160.60M | 120.00M | 71.90M | -11.20M |
| Depreciation & amortization | 51.70M | 54.20M | 60.00M | 57.10M | 53.50M | 58.00M |
| Free cash flow | -33.70M | 34.20M | 119.20M | 55.80M | 28.40M | -70.00M |
| Dividends paid | -2.50M | -2.50M | -2.50M | -2.50M | -2.40M | -2.50M |
| Stock buybacks / issuance | -1.50M | -10.90M | 0 | -500.00K | -30.20M | -1.10M |
| Ending cash balance | 167.90M | 189.70M | 220.00M | 214.60M | 153.20M | 432.10M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 4.90 | 6.46 | 5.75 | 3.62 | 11.83 | 7.02 | 3.92 | 8.21 |
| ROA %i | 4.01 | 5.01 | 4.28 | 2.39 | 7.50 | 4.58 | 2.20 | 4.20 |
| ROIC %i | 4.64 | 6.18 | 5.62 | 3.73 | 9.99 | 6.30 | 3.96 | 7.16 |
| 5-year avg ROE %i | -- | -- | 6.57 | 5.45 | 6.52 | 6.94 | 6.43 | 6.92 |
| EBIT margin %i | 6.57 | 8.84 | 7.69 | 5.25 | 15.48 | 9.71 | 7.82 | 12.14 |
| FCF / sales %i | 5.05 | 15.74 | 9.19 | 4.00 | 1.62 | 2.49 | 12.15 | 6.09 |
| Current ratioi | 3.19 | 2.67 | 2.14 | 2.11 | 2.33 | 2.12 | 1.85 | 2.20 |
| Quick ratioi | 1.87 | 1.55 | 1.15 | 1.05 | 1.35 | 1.07 | 1.04 | 1.26 |
| Debt / assetsi | 8.54 | 4.66 | 9.62 | 21.31 | 16.48 | 15.89 | 34.36 | 30.55 |
| LT debt / equityi | 10.91 | 5.79 | 13.12 | 34.03 | 24.53 | 24.10 | 69.06 | 57.33 |
| Interest coveragei | 106.56 | 22.59 | 14.04 | 4.57 | 11.20 | 7.97 | 2.83 | 3.22 |
| Revenue CAGR (3Y) %i | -11.96 | 0.64 | 9.80 | 11.72 | 8.89 | 6.04 | 8.06 | 8.74 |
| Net income CAGR (3Y) %i | -17.54 | -2.70 | 5.92 | -2.76 | 29.45 | 14.30 | 10.42 | -5.35 |
| FCF CAGR (3Y) %i | -28.82 | 24.11 | 30.72 | 3.37 | -48.98 | -31.36 | 56.55 | 69.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 3.22 | 3.74 | 5.91 | 8.21 | 8.70 | 17.87 |
| ROA %i | 1.81 | 2.09 | 3.15 | 4.20 | 4.47 | 9.51 |
| ROIC %i | 3.82 | 4.47 | 5.97 | 7.16 | 7.41 | 13.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.79 | 8.84 | 11.15 | 12.14 | 12.24 | 12.19 |
| FCF / sales %i | 9.66 | 11.00 | 11.11 | 6.09 | 8.17 | 4.57 |
| Current ratioi | 1.98 | 2.12 | 2.02 | 2.20 | 2.31 | 3.12 |
| Quick ratioi | 1.17 | 1.26 | 1.21 | 1.26 | 1.16 | 2.19 |
| Debt / assetsi | 34.18 | 33.59 | 31.33 | 30.55 | 30.41 | 27.10 |
| LT debt / equityi | 68.25 | 66.71 | 60.88 | 57.33 | 57.04 | 47.90 |
| Interest coveragei | 2.23 | 2.19 | 2.65 | 3.22 | 3.41 | 3.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Construction Products is the largest reported line at 54.20% of revenue, across 2 reported segments.
- Engineered Structures follows at 45.80%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Construction Products54.20%
Engineered Structures45.80%
Quote time 2026-10-07 20:27:01 · For reference only, not investment advice and not tailored to your situation.